₹ 333.04 Cr
2.42%
NIFTY Healthcare TRI
INF966L01CH1
5000.0
1000.0
1000
Sandeep Tandon, Ankit Pande, Varun Pattani, Ayusha Kumbhat, Yug Tibrewal, Sameer Kate, Sanjeev Sharma
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - IDCW Option - Regular Plan | 11.18 | - | - |
| NIFTY Healthcare TRI | 10.83 | 24.82 | 13.98 |
Equity
Debt
Others
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SMS Pharmaceuticals Limited | 10.42 |
| ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/- | 9.29 |
| TREPS 02-Apr-2026 DEPO 10 | 9.16 |
| ASTER DM HEALTHCARE LIMITED EQ | 9.16 |
| Zydus Wellness Limited | 8.38 |
| SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/- | 8.33 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 7.33 |
| PFIZER LIMITED EQ | 6.93 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 5.2 |
| ICICI PRUDENTIAL LIFE INSURANCE CO.LTD EQ | 4.64 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 62.99 |
| Financial Services | 8.76 |
| Fast Moving Consumer Goods | 8.38 |
| Consumer Services | 3.86 |
| Metals & Mining | 0.61 |